Profile: Exiqon A/S provides cellular based diagnostic tests for extreme drug resistance™ and LNA™ based tools for small RNA research. We also specialize in in vitro treatment selection testing for cancer, and perform genomic research aimed at rapidly identifying new cancer diagnostics to improve the outcome for cancer patients. We also offer mircury LNA™ products for microRNA research and microRNA array & PCR services.